GILEAD SCIENCES, INC. Employee Count
The employee counts GILEAD SCIENCES, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2019-12-31: Employees (as filed) 11,800; Filing 2020-02-25.
- 2018-12-31: Employees (as filed) 11,000; Filing 2019-02-26; Lease expense per employee $9,909.09.
- 2017-12-31: Employees (as filed) 10,000; Filing 2018-02-27; Lease expense per employee $8,400.00.
- 2016-12-31: Employees (as filed) 9,000; Filing 2017-02-27; Lease expense per employee $9,000.00.
- Available history
- 2008-12-31 to 2019-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2019-12-31 | 11,800 | 2020-02-25 | |
| 2018-12-31 | 11,000 | 2019-02-26 | $9,909.09 lease and rental expense |
| 2017-12-31 | 10,000 | 2018-02-27 | $8,400.00 lease and rental expense |
| 2016-12-31 | 9,000 | 2017-02-27 | $9,000.00 lease and rental expense |
| 2015-12-31 | 8,000 | 2016-02-24 | $9,750.00 lease and rental expense |
| 2014-12-31 | 7,000 full-time | 2015-02-25 | $9,428.57 lease and rental expense |
| 2013-12-31 | 6,100 full-time | 2014-02-25 | $8,852.46 lease and rental expense |
| 2012-12-31 | 5,000 full-time | 2013-02-27 | $10,800.00 lease and rental expense |
| 2011-12-31 | 4,500 full-time | 2012-02-23 | $10,688.89 lease and rental expense |
| 2010-12-31 | 4,000 full-time | 2011-02-28 | $10,425.00 lease and rental expense |
| 2009-12-31 | 3,852 full-time | 2010-03-01 | $9,683.28 lease and rental expense |
| 2008-12-31 | 3,441 full-time | 2009-02-27 | $8,514.97 lease and rental expense |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |